INTRAGO: intraoperative radiotherapy in glioblastoma multiforme; a phase I/II dose escalation study

Documenti analoghi

• INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
  di: Giordano, Frank Anton, et al.
  Pubblicazione: (2015)
• Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial
  di: Giordano, Frank Anton, et al.
  Pubblicazione: (2026)
• 23Na-MRI of recurrent glioblastoma multiforme after intraoperative radiotherapy: technical note
  di: Haneder, Stefan, et al.
  Pubblicazione: (2014)
• Phase II dose escalation study of caspofungin for invasive aspergillosis
  di: Cornely, Oliver Andreas, et al.
  Pubblicazione: (2011)
• L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial
  di: Giordano, Frank Anton, et al.
  Pubblicazione: (2024)